MaxLinear, Inc.MXLNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank31
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P31
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-4.72%
Q3 202514.94%
Q2 2025-14.89%
Q1 20258.15%
Q4 2024-2.52%
Q3 2024-6.96%
Q2 2024-12.70%
Q1 2024-0.74%
Q4 2023-1.59%
Q3 2023-6.16%
Q2 20235.00%
Q1 2023-8.73%
Q4 2022-3.55%
Q3 2022-4.92%
Q2 202222.02%
Q1 2022-10.14%
Q4 20218.56%
Q3 2021-9.24%
Q2 202117.81%
Q1 2021-10.41%
Q4 202026.32%
Q3 202099.46%
Q2 20208.93%
Q1 20209.47%
Q4 20191.26%
Q3 2019-4.61%
Q2 2019-11.23%
Q1 2019-7.66%
Q4 20182.14%
Q3 2018-3.83%
Q2 2018-2.93%
Q1 20183.68%
Q4 20172.90%
Q3 20170.41%
Q2 201721.51%
Q1 2017-0.65%
Q4 2016-7.28%
Q3 20167.84%
Q2 20161.20%
Q1 20164.91%